Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Two-year efficacy and safety of infliximab treatment in patients with active psoriatic arthritis: findings of the Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT).

Antoni CE, Kavanaugh A, van der Heijde D, Beutler A, Keenan G, Zhou B, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman DD, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen JS.

J Rheumatol. 2008 May;35(5):869-76. Epub 2008 Mar 15.

PMID:
18381786
2.

Are new agents used to treat rheumatoid arthritis safe to take during pregnancy? Organization of Teratology Information Specialists (OTIS) study.

Chambers C, Koren G, Tutuncu ZN, Johnson D, Jones KL.

Can Fam Physician. 2007 Mar;53(3):409-12. Review.

3.

Rheumatic disease in the elderly: rheumatoid arthritis.

Tutuncu Z, Kavanaugh A.

Rheum Dis Clin North Am. 2007 Feb;33(1):57-70. Review.

PMID:
17367692
4.

The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis.

Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, Wu CW, Kavanaugh A.

J Rheumatol. 2007 Jan;34(1):123-9.

PMID:
17216680
5.
6.

Update on anti-tumor necrosis factor therapy in the spondyloarthropathies including psoriatic arthritis.

Kavanaugh A, Tutuncu Z, Catalan-Sanchez T.

Curr Opin Rheumatol. 2006 Jul;18(4):347-53. Review.

PMID:
16763453
7.

Do patients with older-onset rheumatoid arthritis receive less aggressive treatment?

Tutuncu Z, Reed G, Kremer J, Kavanaugh A.

Ann Rheum Dis. 2006 Sep;65(9):1226-9. Epub 2006 Jan 13.

8.

A randomized, blinded, parallel group, placebo controlled pilot study evaluating the effect of PVAC treatment in patients with diffuse systemic sclerosis.

Genovese MC, Chakravarty EF, Boyle DL, Tutuncu Z, Thorburn CM, Halilhodzic M, Kroll S, Baughman J, Stewart S, Kavanaugh A.

J Rheumatol. 2005 Dec;32(12):2345-50.

PMID:
16331761
9.
10.

Rheumatic disease in the elderly: rheumatoid arthritis.

Tutuncu Z, Kavanaugh A.

Clin Geriatr Med. 2005 Aug;21(3):513-25, vi. Review.

PMID:
15911204
11.

Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

Antoni CE, Kavanaugh A, Kirkham B, Tutuncu Z, Burmester GR, Schneider U, Furst DE, Molitor J, Keystone E, Gladman D, Manger B, Wassenberg S, Weier R, Wallace DJ, Weisman MH, Kalden JR, Smolen J.

Arthritis Rheum. 2005 Apr;52(4):1227-36. Erratum in: Arthritis Rheum. 2005 Sep;52(9):2951.

12.

Disease measures in evaluating the effect of anti-TNF therapy and predicting clinical outcome.

Tutuncu Z, Bansal C, Kavanaugh A.

Rheumatology (Oxford). 2004 May;43(5):682-3. No abstract available.

PMID:
15103044
13.

Anti-TNF therapy for other inflammatory conditions.

Tutuncu Z, Morgan GJ Jr, Kavanaugh A.

Clin Exp Rheumatol. 2002 Nov-Dec;20(6 Suppl 28):S146-51. Review.

PMID:
12463467
14.

Interleukin-6, acute phase reactants and clinical status in ankylosing spondylitis.

Tutuncu ZN, Bilgie A, Kennedy LG, Calin A.

Ann Rheum Dis. 1994 Jun;53(6):425-6. No abstract available.

Supplemental Content

Loading ...
Support Center